| Literature DB >> 36159706 |
Lin Gao1,2, Menglin She1, Jiao Shi1, Dongbo Cai1, Dong Wang1, Min Xiong1, Guoming Shen2, Jiaming Gao3, Min Zhang4, Zhifan Yang1, Shouwen Chen1,4.
Abstract
Iturin A is a biosurfactant with various applications, and its low synthesis capability limits its production and application development. Fatty acids play a critical role in cellular metabolism and target product syntheses, and the relationship between fatty acid supplies and iturin A synthesis is unclear. In this study, we attempted to increase iturin A production via strengthening fatty acid synthesis pathways in Bacillus amyloliquefaciens. First, acetyl-CoA carboxylase AccAD and ACP S-malonyltransferase fabD were overexpressed via promoter replacement, and iturin A yield was increased to 1.36 g/L by 2.78-fold in the resultant strain HZ-ADF1. Then, soluble acyl-ACP thioesterase derived from Escherichia coli showed the best performance for iturin A synthesis, as compared to those derived from B. amyloliquefaciens and Corynebacterium glutamicum, the introduction of which in HZ-ADF1 further led to a 57.35% increase of iturin A yield, reaching 2.14 g/L. Finally, long-chain fatty acid-CoA ligase LcfA was overexpressed in HZ-ADFT to attain the final strain HZ-ADFTL2, and iturin A yield reached 2.96 g/L, increasing by 6.59-fold, and the contents of fatty acids were enhanced significantly in HZ-ADFTL2, as compared to the original strain HZ-12. Taken together, our results implied that strengthening fatty acid supplies was an efficient approach for iturin A production, and this research provided a promising strain for industrial production of iturin A.Entities:
Keywords: Bacillus amyloliquefaciens; fatty acid; gene expression; iturin A; metabolic engineering
Year: 2022 PMID: 36159706 PMCID: PMC9500472 DOI: 10.3389/fbioe.2022.974460
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Metabolic engineering of fatty acid synthesis pathways for enhanced production of iturin A.
Strains and plasmids used in this research.
| Strain or plasmid | Relevant genotype/description | Source |
|---|---|---|
| Strain | ||
| | Wild type | Lab collection |
| | CCTCC M2011344 | Lab collection |
|
| ||
| HZ-12 | Iturin A production strain and wild-type (CCTCC M2015234) | Lab collection |
| HZ/pHY300 | Derivative of HZ-12, harboring the plasmid pHY300 as the control strain | This work |
| HZ/pHY-AccAD | Derivative of HZ-12, harboring the AccAD expression plasmid pHY-AccAD | This work |
| HZ/pHY-AccBC | Derivative of HZ-12, harboring the AccBC expression plasmid pHY-AccBC | This work |
| HZ-AD1 | Derivative of HZ-12 and the promoter of genes | This work |
| HZ-AD2 | Derivative of HZ-12 and the promoter of genes | This work |
| HZ-AD3 | Derivative of HZ-12 and the promoter of genes | This work |
| HZ-AD2/pHY300 | Derivative of HZ-AD2, harboring the plasmid pHY300 as the control strain | This work |
| HZ-AD2/pHY- | Derivative of HZ-AD2, harboring the | This study |
| HZ-ADF1 | Derivative of HZ-AD2 and the promoter of gene | This study |
| HZ-ADF2 | Derivative of HZ-AD2 and the promoter of gene | This study |
| HZ-ADF3 | Derivative of HZ-AD2 and the promoter of gene | This study |
| HZ-ADF1/pHY300 | Derivative of HZ-ADF1, harboring the plasmid pHY300 as the control strain | This study |
| HZ-ADF1/pHY-TesABa | Derivative of HZ-ADF1, harboring the TesA expression plasmid pHY-TesABa | This study |
| HZ-ADF1/pHY-TesAEc | Derivative of HZ-ADF1, harboring the TesA expression plasmid pHY-TesAEc | This study |
| HZ-ADF1/pHY-TesACg | Derivative of HZ-ADF1, harboring the TesA expression plasmid pHY-TesACg | This study |
| HZ-ADFT | Derivative of HZ-ADF1 and TesA integration expression strain | This study |
| HZ-ADFT/pHY300 | Derivative of HZ-ADFT, harboring the plasmid pHY300 as the control strain | This study |
| HZ-ADFT/pHY-LcfA | Derivative of HZ-ADFT, harboring the LcfA expression plasmid pHY-LcfA | This study |
| HZ-ADFTL1 | Derivative of HZ-ADFT and the promoter of gene | This study |
| HZ-ADFTL2 | Derivative of HZ-ADFT and the promoter of gene | This study |
| HZ-ADFTL3 | Derivative of HZ-ADFT and the promoter of gene | This study |
| Plasmid | ||
| T2 (2)-Ori |
| Lab collection |
| T2-P43-AccAD | Promoter P43 with the upstream and downstream homogenous arms of PaccAD inserted into T2 (2)-ori | This work |
| T2-PbacA-AccAD | Promoter PbacA with the upstream and downstream homogenous arms of PaccAD inserted into T2 (2)-ori | This work |
| T2-Pdual3-AccAD | Promoter Pdual3 with the upstream and downstream homogenous arms of PaccAD inserted into T2 (2)-ori | This work |
| T2-P43- | Promoter P43 with the upstream and downstream homogenous arms of PfabD inserted into T2 (2)-ori | This study |
| T2-PbacA- | Promoter PbacA with the upstream and downstream homogenous arms of PfabD inserted into T2 (2)-ori | This study |
| T2-Pdual3- | Promoter Pdual3 with the upstream and downstream homogenous arms of PfabD inserted into T2 (2)-ori | This study |
| T2-TesA | TesA integration expression vector | This study |
| T2-P43-LcfA | Promoter P43 with the upstream and downstream homogenous arms of PlcfA inserted into T2 (2)-ori | This study |
| T2-PbacA-LcfA | Promoter PbacA with the upstream and downstream homogenous arms of PlcfA inserted into T2 (2)-ori | This study |
| T2-Pdual3-LcfA | Promoter Pdual3 with the upstream and downstream homogenous arms of PlcfA inserted into T2 (2)-ori | This study |
| pHY300PLK |
| Lab collection |
| pHY-AccAD | AccAD expression vector based on pHY300PLK | This study |
| pHY-AccBC | AccBC expression vector based on pHY300PLK | This study |
| pHY- |
| This study |
| pHY-TesABa | TesABa expression vector based on pHY300PLK | This study |
| pHY-TesAEc | TesAEc expression vector based on pHY300PLK | This study |
| pHY-TesACg | TesACg expression vector based on pHY300PLK | This study |
| pHY-LcfA | LcfA expression vector based on pHY300PLK | This study |
FIGURE 2Effect of acetyl-CoA carboxylase overexpression on iturin A production. (A) Effects of strengthening AccAD and AccBC expressions on iturin A production. (B) Iturin A yields of AccAD overexpression strains mediated by different promoters. (C) Transcriptional level analysis.
FIGURE 3Effect of ACP S-malonyltransferase overexpression on iturin A production. (A) Effects of ACP S-malonyltransferase fabD overexpression on iturin A production. (B) Iturin A yields of fabD overexpression strains mediated by different promoters. (C) Transcriptional level analysis.
FIGURE 4Strengthening soluble acyl-ACP thioesterase expression for iturin A production. (A) Effects of overexpression of acyl-ACP thioesterase from different species on iturin A production. (B) Introducing acyl-ACP thioesterase from E. coli for iturin A production.
FIGURE 5Effect of long-chain fatty acid-CoA ligase overexpression on iturin A production. (A) Effects of long-chain fatty acid-CoA ligase LcfA overexpression on iturin A production. (B) Iturin A yields of LcfA overexpression strains mediated by different promoters. (C) Transcriptional level analysis.
FIGURE 6Fermentation analysis of B. amyloliquefaciens HZ-12 and HZ-ADFTL2 strains. (A) Cell biomass, (B) iturin A yields, and (C) fatty acid concentrations.